Kendall Capital Management Astrazeneca PLC Transaction History

Kendall Capital Management

$422 Million
Q4 2025

A detailed history of Kendall Capital Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Kendall Capital Management holds 8,033 shares of AZN stock, worth $718,150. This represents 0.17% of its overall portfolio holdings.

Number of Shares

8,033

Previous 8,033 -0.0%

Holding current value

$718,150

Previous $616,000 16.56%

% of portfolio

0.17%

Previous 0.15%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$68.72 - $82.11 $1,786 - $2,134	26 Added 0.32%	8,033 $616,000
Q1 2025 Apr 25, 2025	BUY	$65.37 - $77.96 $271,024 - $323,222	4,146 Added 107.38%	8,007 $588,000
Q4 2024 Feb 07, 2025	SELL	$63.2 - $79.58 $1,580 - $1,989	-25 Reduced 0.64%	3,861 $252,000
Q3 2024 Nov 08, 2024	SELL	$76.67 - $87.62 $1,916 - $2,190	-25 Reduced 0.64%	3,886 $302,000
Q2 2024 Aug 12, 2024	SELL	$66.81 - $80.83 $3,340 - $4,041	-50 Reduced 1.26%	3,911 $305,000

Q1 2024 May 10, 2024	BUY	$61.03 - $69.57 $37,838 - $43,133	620 Added 18.56%	3,961 $268,000
Q4 2023 Jan 26, 2024	SELL	$61.89 - $69.28 $1,547 - $1,732	-25 Reduced 0.74%	3,341 $225,000
Q2 2023 Jul 28, 2023	SELL	$69.91 - $75.81 $19,225 - $20,847	-275 Reduced 7.55%	3,366 $241,000
Q4 2022 Jan 30, 2023	SELL	$54.21 - $70.44 $2,710 - $3,522	-50 Reduced 1.35%	3,641 $247,000
Q3 2022 Nov 02, 2022	SELL	$53.02 - $135.75 $5,302 - $13,575	-100 Reduced 2.64%	3,691 $202,000
Q1 2022 May 06, 2022	SELL	$55.72 - $67.12 $6,017 - $7,248	-108 Reduced 2.77%	3,791 $251,000
Q4 2021 Jan 28, 2022	SELL	$54.02 - $63.83 $4,969 - $5,872	-92 Reduced 2.31%	3,899 $227,000
Q3 2021 Nov 05, 2021	BUY	$55.56 - $60.79 $5,889 - $6,443	106 Added 2.73%	3,991 $240,000
Q2 2021 Jul 30, 2021	BUY	$48.42 - $60.18 $188,111 - $233,799	3,885 New	3,885 $233,000
Q4 2020 Feb 08, 2021	SELL	$48.52 - $58.02 $188,500 - $225,407	-3,885 Closed	0 $0
Q3 2020 Oct 22, 2020	SELL	$53.07 - $61.1 $66,337 - $76,375	-1,250 Reduced 24.34%	3,885 $213,000
Q4 2019 Jan 24, 2020	SELL	$42.46 - $50.46 $9,341 - $11,101	-220 Reduced 4.11%	5,135 $256,000
Q3 2019 Nov 12, 2019	SELL	$40.12 - $45.47 $25,075 - $28,418	-625 Reduced 10.45%	5,355 $239,000
Q2 2019 Aug 09, 2019	SELL	$37.28 - $41.68 $10,624 - $11,878	-285 Reduced 4.55%	5,980 $247,000
Q1 2019 May 08, 2019	SELL	$35.49 - $43.02 $12,421 - $15,057	-350 Reduced 5.29%	6,265 $253,000
Q4 2018 Feb 13, 2019	SELL	$36.86 - $41.49 $16,587 - $18,670	-450 Reduced 6.37%	6,615 $251,000
Q3 2018 Oct 29, 2018	SELL	$34.76 - $39.72 $125,136 - $142,992	-3,600 Reduced 33.76%	7,065 $280,000
Q2 2018 Jul 27, 2018	SELL	$34.55 - $37.05 $177,932 - $190,807	-5,150 Reduced 32.56%	10,665 $374,000
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $6,594 - $7,326	-200 Reduced 1.25%	15,815 $553,000
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $513,921 - $557,001	16,015	16,015 $556,000

Others Institutions Holding AZN

# of Institutions

1,548

Shares Held

503M

Call Options Held

5.54M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.

Account

Kendall Capital Management Astrazeneca PLC Transaction History